Stomach Cancer Trial, Recruiting NCT04295473 Sponsor: Nanchong Central Hospital Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT04295473
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with stomach cancer (specifically a type called adenocarcinoma), confirmed by a tissue test, at stages T1 through T4.
  • You are generally able to carry out daily activities with little to no limitation (confirm with trial site).
  • Your liver, kidneys, and other organs are working well enough to handle treatment (confirm with trial site).

Who may not be able to join:

  • Your cancer has spread to other parts of the body (distant metastasis).
  • Your cancer has grown more than 3 cm into the food pipe (oesophagus).
  • Your cancer is a specific aggressive type (called Borrmann type 4) or a large tumour bigger than 8 cm of another type (called Borrmann type 3).
  • You have previously had chemotherapy or radiation therapy for any other cancer.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yunhong Tian, MD, Nanchong Central Hospital

Phone: +86-13508087719

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nanchong Central Hospital
Registry
ClinicalTrials.gov
Start date
2 March 2020
Est. completion
1 March 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

5-year survival rate; 3-year survival rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov